FP7H2020
Glaxosmithkline Vaccines SRL
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 30
- As coordinator
- 14
- EU contribution (CORDIS)
- EUR 10,839,850
- Active
- 2008 to 2020
Projects
30 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| PAVaxA training network for the design of new synthetic carbohydrate-based vaccines to combat antibiotic resistant Pseudomonas aeruginosa | H2020 | 2020 | Participant | EUR 522,999 |
| NEWCARBOVAXNew generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | H2020 | 2017 | Participant | EUR 0 |
| VADEMADoctoral Industrial School for Vaccine Design through Structural Mass Spectrometry | H2020 | 2016 | Coordinator | EUR 516,123 |
| DISSectionDoctoral Industrial School on Human Skin models for Staphylococcal infections | H2020 | 2016 | Coordinator | EUR 516,123 |
| PHA-ST-TRAIN-VACLeveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines | H2020 | 2016 | Participant | EUR 516,123 |
| SVNanoVaxStructural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | H2020 | 2015 | Coordinator | EUR 168,277 |
| DiViNeSustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes | H2020 | 2015 | Participant | EUR 813,999 |
| FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection | FP7 | 2015 | Participant | Not stated |
| GLYCOVAXA training network for the rational design of the next generation of well-defined glycoconjugate vaccines | H2020 | 2015 | Coordinator | EUR 516,123 |
| IMMUNOSHAPEDevelopment of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells | H2020 | 2015 | Partner | EUR 0 |
| DISCOA multidisciplinary Doctoral Industrial School on novel preventive strategies against E. Coli infections | H2020 | 2014 | Coordinator | EUR 522,110 |
| SAMUFLUSelf-amplifying RNA technology applied to the development of a universal influenza vaccine | H2020 | 2014 | Coordinator | EUR 187,415 |
| IMPROVEImproving Prostate Cancer Outcome with Vectored Vaccines | FP7 | 2014 | Participant | EUR 72,002 |
| SV-STAPH-VAXStructural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus | H2020 | 2014 | Coordinator | EUR 187,415 |
| VIPVaccines and Imaging Partnership | H2020 | 2014 | Participant | EUR 444,112 |
| RESTAVACRegulation of Expression of Staphylococcus aureus Vaccine Antigen Candidates | FP7 | 2013 | Coordinator | EUR 179,740 |
| HOMINHost-microbe interactions in health and disease. Interface with the immune system | FP7 | 2013 | Participant | EUR 803,913 |
| MultiMalVaxA Multi-Stage Malaria Vaccine | FP7 | 2012 | Participant | EUR 125 |
| BIOVACSAFEBiomarkers For Enhanced Vaccine Safety | FP7 | 2012 | Coordinator | Not stated |
| VACTRAINTraining network for next generation vaccinologists | FP7 | 2012 | Participant | EUR 254,038 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.